853 related articles for article (PubMed ID: 22763637)
1. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.
Brown-Elliott BA; Nash KA; Wallace RJ
Clin Microbiol Rev; 2012 Jul; 25(3):545-82. PubMed ID: 22763637
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
Brown-Elliott BA; Woods GL
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
[TBL] [Abstract][Full Text] [Related]
3. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
Camarena Miñana JJ; Pellicer RG
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
[TBL] [Abstract][Full Text] [Related]
5. Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility.
Rockland M; Ruth MM; Aalders N; Pennings L; Hoefsloot W; Wattenberg M; van Ingen J
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30760530
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
[TBL] [Abstract][Full Text] [Related]
7. Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines.
Durão V; Silva A; Macedo R; Durão P; Santos-Silva A; Duarte R
Pulmonology; 2019; 25(3):162-167. PubMed ID: 30309821
[TBL] [Abstract][Full Text] [Related]
8. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Sharma M; Malhotra B; Khandelwal S
Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
10. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
[TBL] [Abstract][Full Text] [Related]
11. Identification and drug susceptibility testing for nontuberculous mycobacteria.
Huang WC; Yu MC; Huang YW
J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S32-S41. PubMed ID: 32423573
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Özkarataş MH; Arslan N; Esen N; Özkütük AA
Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
[TBL] [Abstract][Full Text] [Related]
13. Culture, Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria.
Khare R; Brown-Elliott BA
Clin Chest Med; 2023 Dec; 44(4):743-755. PubMed ID: 37890913
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
He G; Wu L; Zheng Q; Jiang X
Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
[No Abstract] [Full Text] [Related]
15. [Nontuberculous Mycobacterial Pulmonary Disease - The New ATS/ERS/ESCMID/IDSA Guideline].
Wagner D; Lange C
Pneumologie; 2020 Nov; 74(11):773-779. PubMed ID: 33202438
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
17.
Brown-Elliott BA; Rubio A; Wallace RJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
[TBL] [Abstract][Full Text] [Related]
18. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Chu HS; Chang SC; Shen EP; Hu FR
PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
[TBL] [Abstract][Full Text] [Related]
19. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
20. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
